Table 3.
Uni- and multivariable cox regression analysis of predictors of disease-free survival.
| Univariable Analysis |
Multivariable Analysis |
|||
|---|---|---|---|---|
| Characteristics | Hazard ratio (95% CI) | P Value | Hazard ratio (95% CI) | P Value |
| Age | 0.999(0.981–1.017) | 0.924 | ||
| BMI | 0.971(0.921–1.022) | 0.267 | ||
| Sex (female vs. male) | 0.784(0.518–1.185) | 0.248 | ||
| Tumor differentiation | ||||
| Well and moderate | Ref | Ref | ||
| Poor | 1.809(1.182–2.769) | 0.006 | 1.740(1.129–2.680) | 0.012* |
| Pre-CRT CEA (≤5 vs. >5) | 1.235 (0.873–1.748) | 0.234 | ||
| Pre-CRT CA199(≤20 vs. >20) | 1.385(0.939–2.044) | 0.101 | ||
| Location (%) | ||||
| Cardia | Ref | Ref | ||
| Corpus | 1.473(0.960–2.261) | 0.076 | 1.132(0.731–1.753) | 0.579 |
| Antrum | 1.170(0.736–1.861) | 0.506 | 1.256(0.786–2.010) | 0.340 |
| Diffuse | 2.768(1.507–5.083) | 0.001 | 2.830(1.524–5.254) | 0.001* |
| Clinical T stage | ||||
| T2 and T3 | Ref | |||
| T4a | 1.298(0.888–1.897) | 0.177 | ||
| T4b | 2.025(1.013–4.048) | 0.046 | ||
| Clinical N stage | ||||
| 0 | Ref | Ref | ||
| 1 | 1.070(0.544–2.105) | 0.844 | 0.870(0.437–1.732) | 0.692 |
| 2 | 1.196(0.620–2.306) | 0.593 | 0.871(0.444–1.710) | 0.688 |
| 3 | 2.893(1.544–5.422) | 0.001 | 2.378(1.250–4.524) | 0.008* |
| DLRN (low vs. high) | 0.446(0.256–0.778) | 0.004 | 0.500(0.283–0.886) | 0.018* |